Top Ultrasonic Aspirator Companies

Global Ultrasonic Aspirator market size was valued at USD 181.03 Million in 2024 and is expected to grow from USD 193.34 Million in 2025 to USD 327.25 Million by 2033, growing at a CAGR of 6.8% in the forecast period (2026–2033).

The global ultrasonic aspirator market is seeing growing competition due to sustained innovation and tactical product enhancements by top players. Companies are focusing on developing their oncology and neurosurgery product portfolios using advanced technology. For example, in August 2024, Bioventus Inc. gained FDA 510(k) clearance for its neXus® SonaStar Elite® handpiece, which forms a part of the neXus Ultrasonic Surgical Aspirator System. This new generation platform, with a proprietary digital algorithm, provides greater versatility and control, indicative of a wider industry shift toward precision, efficiency, and minimally invasive surgical solutions to enhance competitive positioning. 'Stryker Corporation', 'Integra LifeSciences Corporation', 'Olympus Corporation', 'Söring GmbH', 'Bioventus Inc.', 'Richard Wolf GmbH', 'Medtronic plc', 'Biomedicon Systems India Pvt Ltd', 'Meta Dynamic, Inc.', 'Boston Scientific Corporation', 'Toshbro Medicals Pvt. Ltd.', 'Xcellance Medical Technologies', 'Innosurge', 'B. Braun SE', 'Nakanishi Inc.'

Minimally invasive surgery (MIS) is on the rise due to the advantages of smaller incisions, shorter stays in the hospital, and faster recovery compared to traditional open methods. Ultrasonic aspirators are an important part of MIS procedures with the ability to have accurate results with less damage to surrounding tissue. Compatibility with laparoscopic and neuroendoscopic equipment has made ultrasonic aspirators indispensable in neurosurgery, ENT, and gynecology. The global shift toward day-care surgery and patient centered care is thus fueling adoption of ultrasonic aspirators, thus MIS innovation becomes the prevailing market driver.

Short-Term: In the short run, the ultrasonic aspirator market is being driven higher by growing adoption based on increased demand for minimally invasive procedures due to patient demand for faster recovery and less scarring. The precision ultrasonic aspirators deliver with little tissue damage is making them increasingly sought after in neurosurgery, oncology, and other specialized disciplines. Besides that, improvements in ultrasonic technology, as well as advanced features such as real-time tissue feedback and better handpieces, are rendering these systems more effective and efficient for use by surgeons.

North America dominates the ultrasonic aspirator market due to strong healthcare infrastructure, significant healthcare spending, and increased demand for minimally invasive procedures. The U.S. holds more than 85% of the overall regional market share, aided by positive reimbursement policies and a vast patient base. Major players such as Stryker and Integra LifeSciences are targeting this market with next generation systems such as the CUSA Clarity and neXus SonaStar Elite to provide better surgical precision and versatility. These developments, supported by rising cases of neurological and gynecological disorders, drive ultrasonic aspirator demand in the market.